Prime Medicine just dropped its first-ever human clinical data — and immediately laid off 25% of its staff. Nothing says “success” like job cuts. The company proudly deprioritized the exact program that proved its tech works. Bold strategy:... — read more 

Prime Medicine, a biotech whose wild ambitions for a powerful gene editing technology sank as the biotech market slumped, announced Monday it is replacing its CEO, laying off 25% of its staff, and scrapping its lead... — read more